Bontenbal M - Search Results

1

Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7).

Bontenbal M, Sonneveld P, Foekens JA, Klijn JG. Bontenbal M, et al. Eur J Cancer Clin Oncol. 1988 Sep;24(9):1409-14. doi: 10.1016/0277-5379(88)90329-x. Eur J Cancer Clin Oncol. 1988. PMID: 3181264

2

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

Foekens JA, Schmitt M, van Putten WL, Peters HA, Bontenbal M, Jänicke F, Klijn JG. Foekens JA, et al. Among authors: bontenbal m. Cancer Res. 1992 Nov 1;52(21):6101-5. Cancer Res. 1992. PMID: 1394237

3

Clinical breast cancer, new developments in selection and endocrine treatment of patients.

Klijn JG, Berns PM, Bontenbal M, Alexieva-Figusch J, Foekens JA. Klijn JG, et al. Among authors: bontenbal m. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):211-21. doi: 10.1016/0960-0760(92)90210-a. J Steroid Biochem Mol Biol. 1992. PMID: 1445597 Review.

4

Manipulation of cell cycle kinetics: influence on the cytotoxicity of doxorubicin in human breast cancer cells.

Bontenbal M, Sieuwerts AM, Peters HA, Sonneveld P, Foekens JA, Klijn JG. Bontenbal M, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1097-101. doi: 10.1016/0960-0760(90)90472-w. J Steroid Biochem Mol Biol. 1990. PMID: 2285583

5

Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells.

Bontenbal M, Sieuwerts AM, Klijn JG, Peters HA, Krijnen HL, Sonneveld P, Foekens JA. Bontenbal M, et al. Br J Cancer. 1989 Nov;60(5):688-92. doi: 10.1038/bjc.1989.341. Br J Cancer. 1989. PMID: 2679851 Free PMC article.

6

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M, Klijn JG. Foekens JA, et al. Among authors: bontenbal m. Br J Cancer. 1994 Dec;70(6):1217-23. doi: 10.1038/bjc.1994.476. Br J Cancer. 1994. PMID: 7981080 Free PMC article.

7

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Bontenbal M, Foekens JA, Lamberts SW, de Jong FH, van Putten WL, Braun HJ, Burghouts JT, van der Linden GH, Klijn JG. Bontenbal M, et al. Br J Cancer. 1998;77(1):115-22. doi: 10.1038/bjc.1998.18. Br J Cancer. 1998. PMID: 9459155 Free PMC article. Clinical Trial.

8

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

Bontenbal M, Andersson M, Wildiers J, Cocconi G, Jassem J, Paridaens R, Rotmensz N, Sylvester R, Mouridsen HT, Klijn JG, van Oosterom AT. Bontenbal M, et al. Br J Cancer. 1998 Jun;77(12):2257-63. doi: 10.1038/bjc.1998.375. Br J Cancer. 1998. PMID: 9649142 Free PMC article. Clinical Trial.

9

Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro.

Bontenbal M, Sieuwerts AM, Peters HA, van Putten WL, Foekens JA, Klijn JG. Bontenbal M, et al. Breast Cancer Res Treat. 1998 Sep;51(2):139-48. doi: 10.1023/a:1006026015448. Breast Cancer Res Treat. 1998. PMID: 9879776

10

Value of estrogenic recruitment before chemotherapy: first randomized trial in primary breast cancer.

Bontenbal M, van Putten WL, Burghouts JT, Baggen MG, Ras GJ, Stiegelis WF, Beudeker M, Janssen JT, Braun JJ, van der Linden GH, van der Velden PC, van Geel AN, Helle P, Leisink M, Foekens JA, Klijn JG. Bontenbal M, et al. J Clin Oncol. 2000 Feb;18(4):734-42. doi: 10.1200/JCO.2000.18.4.734. J Clin Oncol. 2000. PMID: 10673514 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page